Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3313 to 3321 of 3321 entries
Sorted by: Best Match Show Resources per page
Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces.

The Science of the total environment

Rozwalak P, Podkowa P, Buda J, Niedzielski P, Kawecki S, Ambrosini R, Azzoni RS, Baccolo G, Ceballos JL, Cook J, Di Mauro B, Ficetola GF, Franzetti A, Ignatiuk D, Klimaszyk P, Łokas E, Ono M, Parnikoza I, Pietryka M, Pittino F, Poniecka E, Porazinska DL, Richter D, Schmidt SK, Sommers P, Souza-Kasprzyk J, Stibal M, Szczuciński W, Uetake J, Wejnerowski Ł, Yde JC, Takeuchi N, Zawierucha K.
PMID: 34627905
Sci Total Environ. 2022 Feb 10;807:150874. doi: 10.1016/j.scitotenv.2021.150874. Epub 2021 Oct 08.

Cryoconite is a mixture of mineral and organic material covering glacial ice, playing important roles in biogeochemical cycles and lowering the albedo of a glacier surface. Understanding the differences in structure of cryoconite across the globe can be important...

Cite
Rozwalak P, Podkowa P, Buda J, et al. Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces. Sci Total Environ. 2021;807:150874doi: 10.1016/j.scitotenv.2021.150874.
Rozwalak, P., Podkowa, P., Buda, J., Niedzielski, P., Kawecki, S., Ambrosini, R., Azzoni, R. S., Baccolo, G., Ceballos, J. L., Cook, J., Di Mauro, B., Ficetola, G. F., Franzetti, A., Ignatiuk, D., Klimaszyk, P., Łokas, E., Ono, M., Parnikoza, I., Pietryka, M., Pittino, F., Poniecka, E., Porazinska, D. L., Richter, D., Schmidt, S. K., Sommers, P., Souza-Kasprzyk, J., Stibal, M., Szczuciński, W., Uetake, J., Wejnerowski, �. �., Yde, J. C., Takeuchi, N., & Zawierucha, K. (2022). Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces. The Science of the total environment, 807150874. https://doi.org/10.1016/j.scitotenv.2021.150874
Rozwalak, Piotr, et al. "Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces." The Science of the total environment vol. 807 (2022): 150874. doi: https://doi.org/10.1016/j.scitotenv.2021.150874
Rozwalak P, Podkowa P, Buda J, Niedzielski P, Kawecki S, Ambrosini R, Azzoni RS, Baccolo G, Ceballos JL, Cook J, Di Mauro B, Ficetola GF, Franzetti A, Ignatiuk D, Klimaszyk P, Łokas E, Ono M, Parnikoza I, Pietryka M, Pittino F, Poniecka E, Porazinska DL, Richter D, Schmidt SK, Sommers P, Souza-Kasprzyk J, Stibal M, Szczuciński W, Uetake J, Wejnerowski Ł, Yde JC, Takeuchi N, Zawierucha K. Cryoconite - From minerals and organic matter to bioengineered sediments on glacier's surfaces. Sci Total Environ. 2022 Feb 10;807:150874. doi: 10.1016/j.scitotenv.2021.150874. Epub 2021 Oct 08. PMID: 34627905.
Copy Download .nbib Format: NLM
Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.

The Lancet. Microbe

Schroeder S, Pott F, Niemeyer D, Veith T, Richter A, Muth D, Goffinet C, Müller MA, Drosten C.
PMID: 33969329
Lancet Microbe. 2021 May;2(5):e210-e218. doi: 10.1016/S2666-5247(21)00027-6. Epub 2021 Mar 04.

BACKGROUND: The COVID-19 agent, SARS-CoV-2, is conspecific with SARS-CoV, the causal agent of the severe acute respiratory syndrome epidemic in 2002-03. Although the viruses share a completely homologous repertoire of proteins and use the same cellular entry receptor, their...

Cite
Schroeder S, Pott F, Niemeyer D, et al. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe. 2021;2(5):e210-e218doi: 10.1016/S2666-5247(21)00027-6.
Schroeder, S., Pott, F., Niemeyer, D., Veith, T., Richter, A., Muth, D., Goffinet, C., Müller, M. A., & Drosten, C. (2021). Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. The Lancet. Microbe, 2(5), e210-e218. https://doi.org/10.1016/S2666-5247(21)00027-6
Schroeder, Simon, et al. "Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics." The Lancet. Microbe vol. 2,5 (2021): e210-e218. doi: https://doi.org/10.1016/S2666-5247(21)00027-6
Schroeder S, Pott F, Niemeyer D, Veith T, Richter A, Muth D, Goffinet C, Müller MA, Drosten C. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe. 2021 May;2(5):e210-e218. doi: 10.1016/S2666-5247(21)00027-6. Epub 2021 Mar 04. PMID: 33969329; PMCID: PMC8096348.
Copy Download .nbib Format: NLM
How accurate are digital symptom assessment apps for suggesting conditions and urgency advice? A clinical vignettes comparison to GPs.

BMJ open

Gilbert S, Mehl A, Baluch A, Cawley C, Challiner J, Fraser H, Millen E, Montazeri M, Multmeier J, Pick F, Richter C, Türk E, Upadhyay S, Virani V, Vona N, Wicks P, Novorol C.
PMID: 33328258
BMJ Open. 2020 Dec 16;10(12):e040269. doi: 10.1136/bmjopen-2020-040269.

OBJECTIVES: To compare breadth of condition coverage, accuracy of suggested conditions and appropriateness of urgency advice of eight popular symptom assessment apps.DESIGN: Vignettes study.SETTING: 200 primary care vignettes.INTERVENTION/COMPARATOR: For eight apps and seven general practitioners (GPs): breadth of coverage...

Cite
Gilbert S, Mehl A, Baluch A, et al. How accurate are digital symptom assessment apps for suggesting conditions and urgency advice? A clinical vignettes comparison to GPs. BMJ Open. 2020;10(12):e040269doi: 10.1136/bmjopen-2020-040269.
Gilbert, S., Mehl, A., Baluch, A., Cawley, C., Challiner, J., Fraser, H., Millen, E., Montazeri, M., Multmeier, J., Pick, F., Richter, C., Türk, E., Upadhyay, S., Virani, V., Vona, N., Wicks, P., & Novorol, C. (2020). How accurate are digital symptom assessment apps for suggesting conditions and urgency advice? A clinical vignettes comparison to GPs. BMJ open, 10(12), e040269. https://doi.org/10.1136/bmjopen-2020-040269
Gilbert, Stephen, et al. "How accurate are digital symptom assessment apps for suggesting conditions and urgency advice? A clinical vignettes comparison to GPs." BMJ open vol. 10,12 (2020): e040269. doi: https://doi.org/10.1136/bmjopen-2020-040269
Gilbert S, Mehl A, Baluch A, Cawley C, Challiner J, Fraser H, Millen E, Montazeri M, Multmeier J, Pick F, Richter C, Türk E, Upadhyay S, Virani V, Vona N, Wicks P, Novorol C. How accurate are digital symptom assessment apps for suggesting conditions and urgency advice? A clinical vignettes comparison to GPs. BMJ Open. 2020 Dec 16;10(12):e040269. doi: 10.1136/bmjopen-2020-040269. PMID: 33328258; PMCID: PMC7745523.
Copy Download .nbib Format: NLM
[Awareness and Use of Digital Health Services in Germany: A Cross-sectional Study Representative of the Population].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

Breil B, Dederichs M, Kremer L, Richter D, Angerer P, Apolinário-Hagen J.
PMID: 33862648
Gesundheitswesen. 2021 Dec;83(12):1019-1028. doi: 10.1055/a-1335-4245. Epub 2021 Apr 16.

OBJECTIVES: In light of the current efforts of health policy to implement eHealth, the question arises which sections of the population already use online self-help in order to tailor them to users' needs. The present study aims to determine...

Cite
Breil B, Dederichs M, Kremer L, et al. Bekanntheit und Nutzung von digitalen Gesundheitsangeboten in Deutschland: eine bevölkerungsrepräsentative Querschnittsuntersuchung. [Awareness and Use of Digital Health Services in Germany: A Cross-sectional Study Representative of the Population]. Gesundheitswesen. 2021;83(12):1019-1028doi: 10.1055/a-1335-4245.
Breil, B., Dederichs, M., Kremer, L., Richter, D., Angerer, P., & Apolinário-Hagen, J. (2021). Bekanntheit und Nutzung von digitalen Gesundheitsangeboten in Deutschland: eine bevölkerungsrepräsentative Querschnittsuntersuchung. [Awareness and Use of Digital Health Services in Germany: A Cross-sectional Study Representative of the Population]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 83(12), 1019-1028. https://doi.org/10.1055/a-1335-4245
Breil, Bernhard, et al. "Bekanntheit und Nutzung von digitalen Gesundheitsangeboten in Deutschland: eine bevölkerungsrepräsentative Querschnittsuntersuchung." [Awareness and Use of Digital Health Services in Germany: A Cross-sectional Study Representative of the Population]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) vol. 83,12 (2021): 1019-1028. doi: https://doi.org/10.1055/a-1335-4245
Breil B, Dederichs M, Kremer L, Richter D, Angerer P, Apolinário-Hagen J. Bekanntheit und Nutzung von digitalen Gesundheitsangeboten in Deutschland: eine bevölkerungsrepräsentative Querschnittsuntersuchung. [Awareness and Use of Digital Health Services in Germany: A Cross-sectional Study Representative of the Population]. Gesundheitswesen. 2021 Dec;83(12):1019-1028. doi: 10.1055/a-1335-4245. Epub 2021 Apr 16. German. PMID: 33862648.
Copy Download .nbib Format: NLM
Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Peters N, Wohlfahrt P, Dahlgren CV, de Marzi L, Ellerbrock M, Fracchiolla F, Free J, Gomà C, Góra J, Jensen MF, Kajdrowicz T, Mackay R, Molinelli S, Rinaldi I, Rompokos V, Siewert D, van der Tol P, Vermeren X, Nyström H, Lomax A, Richter C.
PMID: 34329653
Radiother Oncol. 2021 Oct;163:7-13. doi: 10.1016/j.radonc.2021.07.019. Epub 2021 Jul 27.

PURPOSE: Experimental assessment of inter-centre variation and absolute accuracy of stopping-power-ratio (SPR) prediction within 17 particle therapy centres of the European Particle Therapy Network.MATERIAL AND METHODS: A head and body phantom with seventeen tissue-equivalent materials were scanned consecutively at...

Cite
Peters N, Wohlfahrt P, Dahlgren CV, et al. Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy. Radiother Oncol. 2021;163:7-13doi: 10.1016/j.radonc.2021.07.019.
Peters, N., Wohlfahrt, P., Dahlgren, C. V., de Marzi, L., Ellerbrock, M., Fracchiolla, F., Free, J., Gomà, C., Góra, J., Jensen, M. F., Kajdrowicz, T., Mackay, R., Molinelli, S., Rinaldi, I., Rompokos, V., Siewert, D., van der Tol, P., Vermeren, X., Nyström, H., Lomax, A., & Richter, C. (2021). Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1637-13. https://doi.org/10.1016/j.radonc.2021.07.019
Peters, Nils, et al. "Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 163 (2021): 7-13. doi: https://doi.org/10.1016/j.radonc.2021.07.019
Peters N, Wohlfahrt P, Dahlgren CV, de Marzi L, Ellerbrock M, Fracchiolla F, Free J, Gomà C, Góra J, Jensen MF, Kajdrowicz T, Mackay R, Molinelli S, Rinaldi I, Rompokos V, Siewert D, van der Tol P, Vermeren X, Nyström H, Lomax A, Richter C. Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy. Radiother Oncol. 2021 Oct;163:7-13. doi: 10.1016/j.radonc.2021.07.019. Epub 2021 Jul 27. PMID: 34329653.
Copy Download .nbib Format: NLM
EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor.

International journal of molecular sciences

Troitskaya O, Novak D, Nushtaeva A, Savinkova M, Varlamov M, Ermakov M, Richter V, Koval O.
PMID: 34884742
Int J Mol Sci. 2021 Nov 29;22(23). doi: 10.3390/ijms222312937.

Multicellular spheroids with 3D cell-cell interactions are a useful model to simulate the growth conditions of cancer. There is evidence that in tumor spheroids, the expression of various essential molecules is changed compared to the adherent form of cell...

Cite
Troitskaya O, Novak D, Nushtaeva A, et al. EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312937.
Troitskaya, O., Novak, D., Nushtaeva, A., Savinkova, M., Varlamov, M., Ermakov, M., Richter, V., & Koval, O. (2021). EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312937
Troitskaya, Olga, et al. "EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312937
Troitskaya O, Novak D, Nushtaeva A, Savinkova M, Varlamov M, Ermakov M, Richter V, Koval O. EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor. Int J Mol Sci. 2021 Nov 29;22(23). doi: 10.3390/ijms222312937. PMID: 34884742; PMCID: PMC8657849.
Copy Download .nbib Format: NLM
How to win the "Best Paper Award".

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons

Richter M, Rico JVY, Buedts K, Winson I, Marcolli D.
PMID: 33685827
Foot Ankle Surg. 2021 Jun;27(4):349. doi: 10.1016/j.fas.2021.03.001. Epub 2021 Mar 02.

No abstract available.

Cite
Richter M, Rico JVY, Buedts K, et al. How to win the "Best Paper Award". Foot Ankle Surg. 2021;27(4):349doi: 10.1016/j.fas.2021.03.001.
Richter, M., Rico, J. V. Y., Buedts, K., Winson, I., & Marcolli, D. (2021). How to win the "Best Paper Award". Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons, 27(4), 349. https://doi.org/10.1016/j.fas.2021.03.001
Richter, Martinus, et al. "How to win the "Best Paper Award"." Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons vol. 27,4 (2021): 349. doi: https://doi.org/10.1016/j.fas.2021.03.001
Richter M, Rico JVY, Buedts K, Winson I, Marcolli D. How to win the "Best Paper Award". Foot Ankle Surg. 2021 Jun;27(4):349. doi: 10.1016/j.fas.2021.03.001. Epub 2021 Mar 02. PMID: 33685827.
Copy Download .nbib Format: NLM
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Peters N, Wohlfahrt P, Hofmann C, Möhler C, Menkel S, Tschiche M, Krause M, Troost EGC, Enghardt W, Richter C.
PMID: 34774653
Radiother Oncol. 2021 Nov 11;166:71-78. doi: 10.1016/j.radonc.2021.11.002. Epub 2021 Nov 11.

PURPOSE: To quantifiy the range uncertainty in proton treatment planning using dual-energy computed tomography (DECT) for a direct stopping-power prediction (DirectSPR) algorithm and its clinical implementation.METHODS AND MATERIALS: To assess the overall uncertainty in stopping-power ratio (SPR) prediction of...

Cite
Peters N, Wohlfahrt P, Hofmann C, et al. Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction. Radiother Oncol. 2021;166:71-78doi: 10.1016/j.radonc.2021.11.002.
Peters, N., Wohlfahrt, P., Hofmann, C., Möhler, C., Menkel, S., Tschiche, M., Krause, M., Troost, E. G. C., Enghardt, W., & Richter, C. (2021). Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 16671-78. https://doi.org/10.1016/j.radonc.2021.11.002
Peters, Nils, et al. "Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 71-78. doi: https://doi.org/10.1016/j.radonc.2021.11.002
Peters N, Wohlfahrt P, Hofmann C, Möhler C, Menkel S, Tschiche M, Krause M, Troost EGC, Enghardt W, Richter C. Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction. Radiother Oncol. 2021 Nov 11;166:71-78. doi: 10.1016/j.radonc.2021.11.002. Epub 2021 Nov 11. PMID: 34774653.
Copy Download .nbib Format: NLM
Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation.

International journal of cardiology. Heart & vasculature

Ebert M, Karrengarn R, Jahnke C, Kircher S, Oebel S, Döring M, Hindricks G, Paetsch I, Richter S.
PMID: 35024429
Int J Cardiol Heart Vasc. 2021 Dec 29;38:100939. doi: 10.1016/j.ijcha.2021.100939. eCollection 2022 Feb.

INTRODUCTION: Preprocedural cardiovascular magnetic resonance (CMR) or computed tomography (CT) imaging of the left atrium/pulmonary veins is usually employed to guide catheter ablation of atrial fibrillation (AFCA). Incidental findings (IFs) are common on cardiac imaging prior to AFCA. However,...

Cite
Ebert M, Karrengarn R, Jahnke C, et al. Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation. Int J Cardiol Heart Vasc. 2021;38:100939doi: 10.1016/j.ijcha.2021.100939.
Ebert, M., Karrengarn, R., Jahnke, C., Kircher, S., Oebel, S., Döring, M., Hindricks, G., Paetsch, I., & Richter, S. (2022). Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation. International journal of cardiology. Heart & vasculature, 38100939. https://doi.org/10.1016/j.ijcha.2021.100939
Ebert, Micaela, et al. "Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation." International journal of cardiology. Heart & vasculature vol. 38 (2022): 100939. doi: https://doi.org/10.1016/j.ijcha.2021.100939
Ebert M, Karrengarn R, Jahnke C, Kircher S, Oebel S, Döring M, Hindricks G, Paetsch I, Richter S. Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation. Int J Cardiol Heart Vasc. 2021 Dec 29;38:100939. doi: 10.1016/j.ijcha.2021.100939. eCollection 2022 Feb. PMID: 35024429; PMCID: PMC8728394.
Copy Download .nbib Format: NLM
Showing 3313 to 3321 of 3321 entries